comprehensive -WSS

comprehensive

author：knowledge 2025-09-03 03:45:13 - browse：5455

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： It's time to take a new tack for treating Alzheimer's

WSS

'The View' co

Why the advice to take all your antibiotics may be wrong

PBM executives asked to testify by House panel

The creative science of coining drug names

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

How Brent Saunders' Allergan experiment failed

hotspot

comprehensive

A Worst CEO gets some much-needed help

Wikipedia

Cancer drug shortages should be causing more outrage

AI for drug discovery: Experts on separating hype from reality

Hollywood unions extend contract negotiations for actors

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Virginia high school admissions case could be legal follow

Why the advice to take all your antibiotics may be wrong

Hollywood unions extend contract negotiations for actors

Reframing the conversation around gain

Wildfire smoke exposes gaps in outdoor worker protections

Hey, doctors: Don't be no

entertainment

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Florida babysitter arrested over hot car death, authorities say

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Chemotherapy before breast cancer surgery might fuel metastasis

Wikipedia

focus

focus

hotspot